Seely Lynn Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$106,190.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Seely Lynn

According to the SEC Form 4 filings, Seely Lynn, being in a position of

  1. President and CEO at Lyell Immunopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18672 shares for $353,079,
    over all time since 2025-03-14, has bought 175000 shares for $106,190, and sold 26726 shares for $437,910.

Biography of Seely Lynn

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $353,0796100

Comparison of Insiders on Amount of Buys and Sells

2026-08-21SaleLyell Immunopharma, Inc.
LYEL
President and CEO
9,589
0.0411%
$15.54$149,013-30.65%
2026-08-10SaleLyell Immunopharma, Inc.
LYEL
President and CEO
390
0.0017%
$14.34$5,593-23.8%
2026-05-11SaleLyell Immunopharma, Inc.
LYEL
President and CEO
388
0.0016%
$18.91$7,337-32.4%
2026-02-11SaleLyell Immunopharma, Inc.
LYEL
President and CEO
7,455
0.0337%
$23.39$174,372-40.3%
2026-02-10SaleLyell Immunopharma, Inc.
LYEL
President and CEO
438
0.002%
$23.12$10,127-38.55%
2025-11-10SaleLyell Immunopharma, Inc.
LYEL
President and CEO
412
0.002%
$16.11$6,637-1.33%
2025-08-21SaleLyell Immunopharma, Inc.
LYEL
President and CEO
7,257
0.0374%
$10.54$76,518+67.89%
2025-08-12SaleLyell Immunopharma, Inc.
LYEL
President and CEO
406
0.0026%
$10.34$4,197+69.16%
2025-08-11SaleLyell Immunopharma, Inc.
LYEL
President and CEO
391
0.0025%
$10.53$4,116+69%
2025-03-14PurchaseLyell Immunopharma, Inc.
LYEL
President and CEO
175,000
0.0614%
$0.61$106,190+11.7%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.